For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $62.32 in the prior trading day, GeneDx Holdings Corp (NASDAQ: WGS) closed at $67.23, up 7.88%. In other words, the price has increased by $7.88 from its previous closing price. On the day, 2.45 million shares were traded. WGS stock price reached its highest trading level at $67.96 during the session, while it also had its lowest trading level at $61.555.
Ratios:
Our goal is to gain a better understanding of WGS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.07 and its Current Ratio is at 3.25. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Equal Weight rating and assigned the stock a target price of $34.
On July 10, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $43.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 29 ’25 when Feeley Kevin sold 388 shares for $113.09 per share. The transaction valued at 43,879 led to the insider holds 3,337 shares of the business.
Stueland Katherine sold 2,154 shares of WGS for $243,596 on Apr 29 ’25. The Chief Executive Officer now owns 3,440 shares after completing the transaction at $113.09 per share. On Apr 29 ’25, another insider, Kevin Feeley, who serves as the Officer of the company, bought 388 shares for $113.14 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WGS now has a Market Capitalization of 1918179584 and an Enterprise Value of 1848062592. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.81 while its Price-to-Book (P/B) ratio in mrq is 7.45. Its current Enterprise Value per Revenue stands at 5.598 whereas that against EBITDA is 208.915.
Stock Price History:
The Beta on a monthly basis for WGS is 2.04, which has changed by 2.4441597 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, WGS has reached a high of $117.75, while it has fallen to a 52-week low of $18.56. The 50-Day Moving Average of the stock is -28.83%, while the 200-Day Moving Average is calculated to be -1.31%.
Shares Statistics:
The stock has traded on average 1.21M shares per day over the past 3-months and 2045220 shares per day over the last 10 days, according to various share statistics. A total of 28.53M shares are outstanding, with a floating share count of 24.94M. Insiders hold about 12.60% of the company’s shares, while institutions hold 84.25% stake in the company. Shares short for WGS as of 1744675200 were 3252768 with a Short Ratio of 2.70, compared to 1741910400 on 2491153. Therefore, it implies a Short% of Shares Outstanding of 3252768 and a Short% of Float of 28.299999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The company has 4.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0.27, with high estimates of $0.32 and low estimates of $0.21.
Analysts are recommending an EPS of between $1.23 and $0.95 for the fiscal current year, implying an average EPS of $1.1. EPS for the following year is $1.94, with 4.0 analysts recommending between $2.14 and $1.4.
Revenue Estimates
6 analysts predict $85.85M in revenue for the current quarter. It ranges from a high estimate of $86.8M to a low estimate of $84.7M. As of the current estimate, GeneDx Holdings Corp’s year-ago sales were $70.51MFor the next quarter, 6 analysts are estimating revenue of $93.9M. There is a high estimate of $96.8M for the next quarter, whereas the lowest estimate is $91.9M.
A total of 6 analysts have provided revenue estimates for WGS’s current fiscal year. The highest revenue estimate was $374.1M, while the lowest revenue estimate was $367.8M, resulting in an average revenue estimate of $369.4M. In the same quarter a year ago, actual revenue was $305.45MBased on 6 analysts’ estimates, the company’s revenue will be $435.26M in the next fiscal year. The high estimate is $457.2M and the low estimate is $418.76M.
